Clinical Trial Update: A Placebo-Controlled, Double-Blinded, Randomized Trial of Remicade in Korean Patients With Rheumatoid Arthritis Despite Methotrexate (Study P04280)(COMPLETED) [Phase 3]

View source ↗

Summary

A completed Phase 3, randomized, double-blind, placebo-controlled trial evaluated infliximab (Remicade) in Korean patients with rheumatoid arthritis despite met…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Remicade (infliximab)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Arthritis, Rheumatoid | Phase 3 | Status: COMPLETED